Sfoglia per RIVISTA
ONCOTARGET
Collezione ASL Cuneo 2
Items : 1
Phase 1B/2 study of the HSP90 inhibitor AUY922 plus trastuzumab in metastatic HER2-positive breast cancer patients who have progressed on trastuzumab-based regimen. in Oncotarget / Oncotarget. 2016 Jun 21;7(25):37680-37692. doi: 10.18632/oncotarget.8974.
2016
ASL Cuneo 2
Hsu Schmitz SF; Campone M; Alba E; Aglietta M; Armstrong AC; Biganzoli L; López López R; Beck JT; Ahmed S; Rea D; Kong A; Lefebvre C; Akimov M; Lee SC;